Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy

Study:

n/a

Rationale:

n/a

Purpose:

The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Painful Diabetic Neuropathy Drug: placebo
Drug: topical clonidine (ARC-4558)
Phase 2

Verified by Arcion Therapeutics Inc January, 2010

Sponsored by: Arcion Therapeutics Inc
Information provided by: Arcion Therapeutics Inc
ClinicalTrials.gov identifier: NCT00695565

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site